<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03173300</url>
  </required_header>
  <id_info>
    <org_study_id>GLY-000</org_study_id>
    <nct_id>NCT03173300</nct_id>
  </id_info>
  <brief_title>Natural History Study Protocol in PMM2-CDG (CDG-Ia)</brief_title>
  <official_title>Clinical and Basic Investigations Into Phosphomannomutase Deficiency (PMM2-CDG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glycomine, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glycomine, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical and Basic Investigations into Phosphomannomutase deficiency (PMM2-CDG)

      This is a natural history (observational) protocol designed to collect clinical and
      biological information in patients with PMM2-CDG (CDG-Ia).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects enrolled in this natural history study will be thoroughly examined for signs and
      symptoms of PMM2-CDG. Medical history, physical examination, laboratory testing and imaging
      studies will be performed during a single consultation. Follow-up will occur every 6 months
      at a minimum, depending on the standard of care at the investigator's institution as well as
      the clinical status of the individual patient. All medical procedures are routine. No new
      therapy is offered as part of this study, and no change in the patients' routine therapy is
      dictated by this protocol. No randomization will be performed.

      All serious and non-serious adverse events will be recorded in the study CRF database.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>collect clinical and biological information in patients with CDG-PMM2</measure>
    <time_frame>up to 4 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Phosphomannomutase 2 Deficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with PMM2-CDG, all ages
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent/assent by the patient and/or their legally authorized representative

          -  Confirmed diagnosis of PMM2-CDG, based on enzymatic or molecular tests

          -  Willing and able to adhere to study requirements described in the protocol and
             consent/assent documents

        Exclusion Criteria:

          -  Known or suspected differential diagnosis of any other known CDG (not PMM2-CDG)

          -  Currently using investigational drug

          -  Blood loss of &gt;250 mL or donated blood within 56 days, or donated plasma within 7
             days, of study screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horacio Plotkin, MD / Chief Medical Officer</last_name>
    <role>Study Director</role>
    <affiliation>Glycomine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Horacio Plotkin, MD / Chief Medical Officer</last_name>
    <phone>+1 (781) 290-3722</phone>
    <email>hplotkin@glycomine.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tulane University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic College of Medicine</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Bohlen, Study Coordinator</last_name>
      <phone>507-293-7485</phone>
      <email>bohlen.sarah@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Eva Morava-Kozicz, MD, PhD</last_name>
      <phone>504-444-9386</phone>
      <email>morava-kozicz.eva@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Patterson, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia (CHOP)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nia Nichols</last_name>
      <phone>267-426-0186</phone>
      <email>nicholsn@chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Edmondson, MD, PhD</last_name>
      <phone>215-313-4607</phone>
      <phone_ext>22178</phone_ext>
      <email>edmondsona@email.chop.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Can Ficicioglu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hayden Vreugdenhil</last_name>
      <phone>206-884-1264</phone>
      <email>hayden.vreugdenhil@seattlechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Christina Lam, MD</last_name>
      <email>christina.lam@seattlechildrens.com</email>
    </contact_backup>
    <investigator>
      <last_name>Christina Lam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nele Vanhoutvin, Paramedisch coördinator Metabole Ziekten</last_name>
      <phone>+32 16 34 19 47</phone>
      <email>nele.vanhoutvin@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Peter Witters, MD, PhD</last_name>
      <email>peter.witters@uzleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Witters, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General University Hospital in Prague</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Čechová, MD</last_name>
      <email>anina.cech@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Tomas Honzik, MD, PhD</last_name>
      <email>tomas.honzik@vfn.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Tomas Honzik, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Necker Enfants-Malades Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Bauchart, PhD</last_name>
      <email>eric.bauchart@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pascale de Lonlay, MD</last_name>
      <email>pdelonlay@neuf.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pascale de Lonlay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Catania</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rita Barone, MD, PhD</last_name>
      <email>rbarone@unict.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud University Nejmegen Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mirian Janssen, MD PhD</last_name>
      <phone>+31 24 361 8819</phone>
      <email>mirian.janssen@radboudumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mother and Child Institute (Instytut Matki i Dziecka)</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jolanta Sykut-Cegielska, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dulce Quelhas, MD</last_name>
      <email>dulce.quelhas@chporto.min-saude.pt</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>United Kingdom</country>
  </removed_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PMM2-CDG</keyword>
  <keyword>CDG-Ia</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

